Can CBD Help With PTSD?

Post-traumatic stress disorder (PTSD) affects an estimated 1.1 to 2.9% of the adult population in Europe, and among veterans and victims of violence those numbers rise several times over. In this article you will see what current clinical research says about the use of CBD for PTSD, how cannabidiol acts on the brain circuits associated with fear, and what doses are being investigated in real-world studies.

What Is PTSD and Why Is It So Difficult to Treat

Post-traumatic stress disorder is a psychiatric diagnosis that develops following exposure to a traumatic event — war, a road accident, physical or sexual violence, a natural disaster, or prolonged domestic abuse. According to American researchers, approximately 70% of the population will experience at least one traumatic event in their lifetime, and 8% of those will develop full-blown PTSD.

The core symptoms of PTSD according to DSM-5 include:

• Intrusive memories and flashbacks to the trauma
• Nightmares related to the event
• Hyperarousal — heightened irritability, vigilance, and startle response
• Avoidance of stimuli that remind one of the trauma
• Negative changes in thinking and mood — emotional numbing, guilt, shame
• Sleep disturbances — insomnia and frequent nocturnal awakenings

Standard treatment involves psychotherapy (particularly prolonged exposure and EMDR) and SSRI antidepressants. The problem is that an estimated 30–50% of patients do not respond adequately to these treatments, which has led researchers to look for complementary interventions. This is where CBD enters the picture.

How CBD Acts in the Brain in the Context of PTSD

CBD (cannabidiol) is the non-psychoactive component of cannabis that interacts with several neurochemical systems associated with fear and anxiety. The mechanism by which CBD may help with PTSD operates on three levels. If you would first like to read about how CBD acts in the body generally, we recommend the article CBD drops and their effects.

The Endocannabinoid System and Fear Regulation

The endocannabinoid system (ECS) is a network of receptors and signalling molecules in the brain that regulates stress, mood, sleep, and memory. CB1 and CB2 receptors are particularly abundant in the amygdala and hippocampus — the areas that determine how the brain processes and stores fear memories. In PTSD, ECS signalling is typically disrupted, leading to the brain becoming “trapped” in the traumatic memory.

CBD indirectly increases levels of anandamide (the body’s own endocannabinoid) by blocking the FAAH enzyme that breaks it down. Higher anandamide levels help the brain process fear memories without them being reactivated.

The 5-HT1A Receptor and the Serotonin Pathway

CBD is a partial agonist of the serotonin receptor 5-HT1A, which plays a key role in regulating anxiety, hyperarousal, and sleep. This mechanism is similar to that of some anxiolytics, but with a substantially better safety profile and no addictive potential.

Extinction Learning — the Key to Trauma Treatment

The latest research highlights CBD’s ability to support so-called extinction learning — the process through which the brain “unlearns” a fear response to stimuli that are no longer dangerous. This is exactly what prolonged exposure therapy does: gradually exposing the patient to trauma-related stimuli until fear diminishes. Studies suggest CBD accelerates and enhances this process, which is why it is being investigated primarily as an adjunct to psychotherapy, not a replacement for it.

What Clinical Studies Have Found About CBD for PTSD

The scientific evidence for CBD in PTSD is still at an early stage, but the first results are promising. Here are the most important findings.

Elms 2019 — a Landmark Case Series

The most frequently cited clinical study is the retrospective case series by Elms and colleagues from 2019, published in the Journal of Alternative and Complementary Medicine. It followed 11 patients with PTSD who took oral CBD alongside standard psychiatric care for 8 weeks.

The results were remarkable:

• 91% of patients (10 of 11) reported a reduction in the severity of PTSD symptoms according to the standardised PCL-5 questionnaire
• The average PCL-5 score fell by 28% (from 51.82 to 37.14)
• No patient discontinued treatment due to side effects
• CBD brought the greatest relief to patients suffering from nightmares

The study has obvious limitations — a small sample, retrospective design, absence of a placebo, and the fact that patients were simultaneously receiving routine psychiatric treatment. These objections were raised in the critique by Stuyt and Hilderbrand (2020), who noted that improvement cannot be unambiguously attributed to CBD alone. Nevertheless, the results opened the door to larger and better-designed studies.

Currently Ongoing Trials

The current research landscape has deployed several serious randomised controlled trials on CBD for PTSD:

• NYU Langone Health is running an 8-week double-blind trial with 120 participants, comparing CBD 400 mg and 800 mg daily with placebo in patients with PTSD and co-occurring mild traumatic brain injury
• UCSD and VA San Diego have launched a trial with 136 military veterans receiving CBD or placebo as an adjunct to prolonged exposure therapy
• A pilot RCT published in PMC in 2024 investigates the combination of CBD (Epidiolex 250 mg twice daily) with intensive exposure therapy over 18 days

The results of these studies are expected in 2026 and 2027 and are anticipated to significantly advance the evidence base.

Critical Notes

For a balanced view, it must be noted that not all studies show an unambiguously positive effect. Some preclinical studies in rodents suggested that CBD administered before fear conditioning may paradoxically increase the expression of generalised fear and inhibit extinction learning. These conflicting findings are attributed to differences in doses, timing of administration, and animal models. In humans in a clinical context, positive results predominate so far, but more double-blind studies are needed.

Which PTSD Symptoms May Respond to CBD

Based on existing studies and clinical reports, CBD for PTSD appears potentially useful particularly for the following manifestations:

• Nightmares — Elms 2019 explicitly highlighted relief in patients suffering from recurrent nightmares; CBD modulates the REM phase of sleep
• Hyperarousal and vigilance — through action on the 5-HT1A receptor and reduction of autonomic activation
• Anxiety component — multiple studies show an anxiolytic effect of CBD in social anxiety and generalised anxiety, whose mechanism overlaps with PTSD
• Sleep disturbances — not only nightmares but also insomnia and fragmented sleep; more in the article Quality Sleep: How to Fight Insomnia
• Intrusive memories — CBD may weaken the consolidation of traumatic memories during repeated exposures

Conversely, negative emotional symptoms (guilt, shame, emotional numbing) and avoidance behaviour do not appear to be directly affected by CBD — here psychotherapy remains the mainstay of treatment.

What Doses of CBD for PTSD Does Research Use

What doses are being investigated in a clinical context? Here are the figures:

• Elms 2019: flexible dosing, most patients 25–175 mg CBD daily
• NYU Langone trial: fixed doses of 400 mg and 800 mg daily
• Pilot RCT 2024: 250 mg twice daily (i.e. 500 mg/day) as Epidiolex
• Common clinical practice outside trials: 50–150 mg daily

For practical use in PTSD, doses are therefore substantially higher than for general anxiety or wellness support. Realistically they fall between 50 and 200 mg daily, which with CBD oil 15% full spectrum means 7–27 drops per day, ideally split between morning and evening administration.

For PTSD specifically, we recommend:

• Starting slowly — even if the target dose will be higher, begin with 20–30 mg daily during the first week
• Consistency — the effect on anxiety circuits is cumulative; missing days breaks the effect
• Evening dose — for problems with nightmares and sleep, a boosted evening dose is key
• Consultation with a specialist — given possible interactions with SSRIs and other psychoactive medications

A detailed protocol for safely increasing doses can be found in the article How to Dose CBD: How Much to Take and How to Start.

Which Type of CBD Is Most Suitable for PTSD

Scientific studies on CBD for PTSD most commonly use highly pure cannabidiol in the form of Epidiolex (a CBD isolate). In real-world practice, however, full-spectrum CBD often has an advantage — it contains additional cannabinoids (CBG, CBN, trace THC) and terpenes that together create the so-called entourage effect. Some of these components are independently being studied for their calming and sedative properties:

• CBN (cannabinol) — produced by the oxidation of THC, has a pronounced sedative effect and in combination with CBD can improve sleep during nightmares
• CBG (cannabigerol) — acts anxiolytically via different receptors than CBD, may be useful for morning anxiety and hyperarousal
• Linalool, myrcene, beta-caryophyllene — terpenes with demonstrated anti-anxiety action in preclinical research

When choosing an oil for PTSD, we therefore recommend higher concentrations to avoid taking dozens of drops per day:

• CBD oil 10% full spectrum — suitable for the initial titration phase and moderate doses
• CBD oil 15% full spectrum — optimal for long-term use in PTSD, best cost-to-potency ratio

For those who prefer a dual cannabinoid profile, a combination of CBD oil with CBG oil 10% may be interesting — taking CBG in the morning (for focus and daytime anxiolysis) and CBD in the evening (for calming and sleep).

In PTSD, quality and product certification is especially important. Studies show that independent testing of many commercial CBD products reveals significant discrepancies between declared and actual CBD content — some contain up to 30% less active compound, and some contain undeclared traces of THC. In patients with PTSD who often also take other psychoactive medications, this can be a critical issue. Always choose oils with laboratory certificates and a clear origin.

How to Combine CBD With Psychotherapy for PTSD

The most promising direction in CBD for PTSD research is not CBD alone, but the combination of CBD with evidence-based psychotherapy — particularly prolonged exposure (PE) and EMDR. The mechanism we mentioned — extinction learning — is precisely what PE does: repeated, controlled exposure to traumatic stimuli in a safe therapeutic environment.

How to combine CBD with therapy in practice:

• CBD before a therapy session — some clinicians recommend 25–50 mg CBD 60–90 minutes before therapy to reduce autonomic activation (rapid pulse, hyperventilation) during exposure to traumatic material
• CBD as support between sessions — regular daily use helps with PE homework (writing the trauma narrative, in-vivo exposure exercises)
• CBD for nightmares between sessions — particularly for patients whose PE temporarily intensifies nightmares in the early weeks
• CBD for post-session anxiety — some PE sessions can be emotionally demanding; CBD can assist with evening nervous system regulation

The key point, however, is that CBD should never replace psychotherapy in PTSD — it serves as a facilitator that can increase the chances of therapeutic success and improve tolerance of its more demanding phases. Patients who add CBD on their own without therapy may experience temporary relief, but without processing the trauma the core of PTSD remains untouched.

If you or someone close to you is struggling with PTSD, the first step should be professional diagnosis by a psychiatrist or psychologist specialising in trauma. CBD can be part of a broader strategy, but never a replacement for it.

Safety of CBD for PTSD and When to Seek Professional Help

CBD has a generally favourable safety profile — WHO in its Critical Review Report from 2018 described it as well tolerated even at doses of several hundred milligrams per day. However, when using CBD for PTSD there are specific limitations to bear in mind:

• Interactions with SSRI antidepressants — CBD affects CYP450 liver enzymes that metabolise sertraline, paroxetine, and fluoxetine; effects may be amplified
• Concurrent use of benzodiazepines — CBD can enhance the sedative effect
• Anticonvulsants — medical supervision is required when combined with clonazepam or valproate
• PTSD and substance use — patients with PTSD have an increased risk of alcohol and opioid dependence; CBD is not addictive, but self-treatment without professional therapy can mask the need for more comprehensive help
• Pregnancy and breastfeeding — both EFSA and WHO recommend avoiding CBD

The most important conclusion from research is that CBD is not a primary treatment for PTSD. None of the studies cited claim that CBD replaces psychotherapy or medication. It is rather a potentially useful adjunct that can increase the effectiveness of existing approaches, reduce the severity of specific symptoms, and improve sleep quality during therapy.

Summary: The State of CBD for PTSD Research in 2026

Current scientific evidence on CBD for PTSD suggests that cannabidiol may help particularly with sleep, nightmares, hyperarousal, and the anxiety component — through its action on the endocannabinoid system and serotonin receptors. Clinical studies so far show positive results, although high-quality double-blind RCTs remain scarce. The latest trials from NYU and UCSD will provide the necessary data within the next two years. When experimenting with CBD for PTSD, always consult a doctor and choose a certified full-spectrum CBD oil from a trustworthy source — at our farm beneath Kriváň we grow hemp by hand without pesticides, so you know exactly what you are taking.

Sources

• Elms L, Shannon S, Hughes S, Lewis N. Cannabidiol in the Treatment of Post-Traumatic Stress Disorder: A Case Series. J Altern Complement Med, 2019;25(4):392–397
• NYU Langone Health, Cannabidiol for Treating PTSD symptoms and Neurocognitive Impairment — Phase II RCT
• UCSD & VA San Diego, Cannabidiol as an Adjunctive to Prolonged Exposure for the Treatment of PTSD (NCT03518801)
• Pilot RCT, Enhancing massed prolonged exposure with cannabidiol to improve posttraumatic stress disorder, PMC 2024
• Bitencourt RM, Takahashi RN. Cannabidiol as a Therapeutic Alternative for Post-Traumatic Stress Disorder: From Bench Research to Confirmation in Human Trials. Frontiers in Neuroscience, 2018
• WHO Expert Committee on Drug Dependence, Cannabidiol (CBD) Critical Review Report, 2018